 | More than 8,900 researchers and developers at Eli Lilly and Company rely on compliant, easy access to scientific publications, key journals, congress and meeting abstracts, and other important research to fuel their various stages of drug development. How do their Legal and Library teams effectively manage seamless access to scientific content and copyright compliance while supporting R&D, medical affairs, regulatory, and other teams across the globe? View CCC and Lilly’s new success story for insights into the tools they use and specific use cases for how they are applied to empower teams across the drug development pipeline. Hear directly from senior members of Lilly’s Library and Legal teams on how their information management and copyright compliance programs come together to:
Request Free! |
